Outpatient use of anticoagulants, rate-controlling drugs, and antiarrhythmic drugs for atrial fibrillation

American Heart Journal

Volumn 154, Issue 5, 2007, Pages 893-898

  Allen LaPointe, Nancy M ^a   Governale, Laura ^b   Watkins, Jerry ^a   Mulgund, Jyotsna ^a   Anstrom, Kevin J ^a  

^a DUKE UNIVERSITY MEDICAL CENTER   (United States)

^b CENTER FOR DRUG EVALUATION AND RESEARCH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMIODARONE; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; DIGOXIN; DILTIAZEM; DISOPYRAMIDE; DOFETILIDE; FLECAINIDE; PROCAINAMIDE; PROPAFENONE; QUINIDINE; SOTALOL; VERAPAMIL; WARFARIN;

ANTICOAGULANT THERAPY; ARTICLE; CONTROLLED STUDY; ELDERLY CARE; EVIDENCE BASED MEDICINE; HEART ATRIUM FIBRILLATION; HUMAN; HUMAN EXPERIMENT; NORMAL HUMAN; OUTPATIENT CARE; PATIENT COMPLIANCE; PRIORITY JOURNAL;

ADRENERGIC BETA-ANTAGONISTS; ANTI-ARRHYTHMIA AGENTS; ANTICOAGULANTS; ATRIAL FIBRILLATION; CALCIUM CHANNEL BLOCKERS; FOLLOW-UP STUDIES; HEART RATE; HUMANS; MIDDLE AGED; OUTPATIENTS; RETROSPECTIVE STUDIES; TREATMENT OUTCOME;

EID: 35548961833     PISSN: 00028703     EISSN: 10976744     Source Type: Journal    
DOI: 10.1016/j.ahj.2007.06.035     Document Type: Article

References (24)

1. Hylek E.M., Go A.S., Chang Y., et al. Effect of intensity of oral anticoagulation on stroke severity and mortality in atrial fibrillation. N Engl J Med 349 (2003) 1019-1026
2. Marshall D.A., Levy A.R., Vidaillet H., et al. Cost-effectiveness of rhythm versus rate control in atrial fibrillation. Ann Intern Med 141 (2004) 653-661
3. de Denus S., Sanoski C.A., Carlsson J., et al. Rate vs rhythm control in patients with atrial fibrillation: a meta-analysis. Arch Intern Med 165 (2005) 258-262
4. Fuster V., Ryden L.E., Asinger R.W., et al. ACC/AHA/ESC guidelines for the management of patients with atrial fibrillation: executive summary. A report of the American College of Cardiology/ American Heart Association Task Force on Practice Guidelines and the European Society of Cardiology Committee for Practice Guidelines and Policy Conferences (Committee to Develop Guidelines for the Management of Patients with Atrial Fibrillation): developed in collaboration with the North American Society of Pacing and Electrophysiology. J Am Coll Cardiol 38 (2001) 1231-1266
5. Stafford R.S., and Radley D.C. The underutilization of cardiac medications of proven benefit, 1990 to 2002. J Am Coll Cardiol 41 (2003) 56-61
6. Fang M.C., Stafford R.S., Ruskin J.N., et al. National trends in antiarrhythmic and antithrombotic medication use in atrial fibrillation. Arch Intern Med 164 (2004) 55-60
7. Reynolds M.R., Shah J., Essebag V., et al. Patterns and predictors of warfarin use in patients with new-onset atrial fibrillation from the FRACTAL Registry. Am J Cardiol 97 (2006) 538-543
8. Wang T.J., Massaro J.M., Levy D., et al. A risk score for predicting stroke or death in individuals with new-onset atrial fibrillation in the community: the Framingham Heart Study. JAMA 290 (2003) 1049-1056
9. Snow V., Weiss K.B., LeFevre M., et al. Management of newly detected atrial fibrillation: a clinical practice guideline from the American Academy of Family Physicians and the American College of Physicians. Ann Intern Med 139 (2003) 1009-1017
10. Fuster V., Ryden L.E., Cannom D.S., et al. ACC/AHA/ESC 2006 guidelines for the management of patients with atrial fibrillation: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the European Society of Cardiology Committee for Practice Guidelines (Writing Committee to Revise the 2001 Guidelines for the Management of Patients With Atrial Fibrillation): developed in collaboration with the European Heart Rhythm Association and the Heart Rhythm Society. Circulation 114 (2006) e257-e354
11. Gage B.F., Waterman A.D., Shannon W., et al. Validation of clinical classification schemes for predicting stroke: results from the National Registry of Atrial Fibrillation. JAMA 285 (2001) 2864-2870
12. Corley S.D., Epstein A.E., DiMarco J.P., et al. Relationships between sinus rhythm, treatment, and survival in the Atrial Fibrillation Follow-Up Investigation of Rhythm Management (AFFIRM) Study. Circulation 109 (2004) 1509-1513
13. Wyse D.G., Waldo A.L., DiMarco J.P., et al. A comparison of rate control and rhythm control in patients with atrial fibrillation. N Engl J Med 347 (2002) 1825-1833
14. Van I., Gelder C., Hagens V.E., Bosker H.A., et al. A comparison of rate control and rhythm control in patients with recurrent persistent atrial fibrillation. N Engl J Med 347 (2002) 1834-1840
15. Hohnloser S.H., and Kuck K.H. Atrial fibrillation: maintaining stability of sinus rhythm or ventricular rate control? The need for prospective data: the PIAF trial. Pacing Clin Electrophysiol 20 (1997) 1989-1992
16. Carlsson J., Miketic S., Windeler J., et al. Randomized trial of rate-control versus rhythm-control in persistent atrial fibrillation: the Strategies of Treatment of Atrial Fibrillation (STAF) study. J Am Coll Cardiol 41 (2003) 1690-1696
17. Page R.L. Clinical practice. Newly diagnosed atrial fibrillation. N Engl J Med 351 (2004) 2408-2416
18. O'Hara G.E., Charbonneau L., Chandler M., et al. Comparison of management patterns and clinical outcomes in patients with atrial fibrillation in Canada and the United States (from the analysis of the Atrial Fibrillation Follow-up Investigation of Rhythm Management [AFFIRM] database). Am J Cardiol 96 (2005) 815-821
19. Kanoupakis E.M., Manios E.G., Mavrakis H.E., et al. Comparative effects of carvedilol and amiodarone on conversion and recurrence rates of persistent atrial fibrillation. Am J Cardiol 94 (2004) 659-662
20. Singh S.N., Singh B.N., Reda D.J., et al. Comparison of sotalol versus amiodarone in maintaining stability of sinus rhythm in patients with atrial fibrillation (Sotalol-Amiodarone Fibrillation Efficacy Trial [Safe-T]). Am J Cardiol 92 (2003) 468-472
21. Singh B.N., Singh S.N., Reda D.J., et al. Amiodarone versus sotalol for atrial fibrillation. N Engl J Med 352 (2005) 1861-1872
22. Hauser T.H., Pinto D.S., Josephson M.E., et al. Early recurrence of arrhythmia in patients taking amiodarone or class 1C agents for treatment of atrial fibrillation or atrial flutter. Am J Cardiol 93 (2004) 1173-1176
23. Letelier L.M., Udol K., Ena J., et al. Effectiveness of amiodarone for conversion of atrial fibrillation to sinus rhythm: a meta-analysis. Arch Intern Med 163 (2003) 777-785
24. Radley D.C., Finkelstein S.N., and Stafford R.S. Off-label prescribing among office-based physicians. Arch Intern Med 166 (2006) 1021-1026